212 related articles for article (PubMed ID: 2465790)
1. Plasma cell myeloma--new biological insights and advances in therapy.
Barlogie B; Epstein J; Selvanayagam P; Alexanian R
Blood; 1989 Mar; 73(4):865-79. PubMed ID: 2465790
[TBL] [Abstract][Full Text] [Related]
2. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
Lauta VM
Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
[TBL] [Abstract][Full Text] [Related]
3. Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features.
Grogan TM; Durie BG; Lomen C; Spier C; Wirt DP; Nagle R; Wilson GS; Richter L; Vela E; Maxey V
Blood; 1987 Oct; 70(4):932-42. PubMed ID: 3115338
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement.
Epstein J; Barlogie B; Katzmann J; Alexanian R
Blood; 1988 Apr; 71(4):861-5. PubMed ID: 2451550
[TBL] [Abstract][Full Text] [Related]
5. Advances in biology and therapy of multiple myeloma.
Barillé-Nion S; Barlogie B; Bataille R; Bergsagel PL; Epstein J; Fenton RG; Jacobson J; Kuehl WM; Shaughnessy J; Tricot G
Hematology Am Soc Hematol Educ Program; 2003; ():248-78. PubMed ID: 14633785
[TBL] [Abstract][Full Text] [Related]
6. Myeloma phenotype: clues to disease origin and manifestation.
Epstein J
Hematol Oncol Clin North Am; 1992 Apr; 6(2):249-56. PubMed ID: 1582972
[TBL] [Abstract][Full Text] [Related]
7. High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myeloma.
Barlogie B; Smallwood L; Smith T; Alexanian R
Ann Intern Med; 1989 Apr; 110(7):521-5. PubMed ID: 2647015
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma.
Harousseau JL; Shaughnessy J; Richardson P
Hematology Am Soc Hematol Educ Program; 2004; ():237-56. PubMed ID: 15561686
[TBL] [Abstract][Full Text] [Related]
9. Biology and treatment of multiple myeloma.
Niesvizky R; Siegel D; Michaeli J
Blood Rev; 1993 Mar; 7(1):24-33. PubMed ID: 8467229
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
[TBL] [Abstract][Full Text] [Related]
11. The clonogenic precursor cell in multiple myeloma.
Bakkus MH; Van Riet I; De Greef C; Van Camp B; Thielemans K
Leuk Lymphoma; 1995 Jul; 18(3-4):221-9. PubMed ID: 8535186
[TBL] [Abstract][Full Text] [Related]
12. Extensive extramedullary disease in myeloma. An uncommon variant with features of poor prognosis and dedifferentiation.
Sanal SM; Yaylaci M; Mangold KA; Pantazis CG
Cancer; 1996 Apr; 77(7):1298-302. PubMed ID: 8608506
[TBL] [Abstract][Full Text] [Related]
13. Homing mechanisms in the biology of multiple myeloma.
Van Camp B; Van Riet I
Verh K Acad Geneeskd Belg; 1998; 60(3):163-94. PubMed ID: 9803879
[TBL] [Abstract][Full Text] [Related]
14. IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells.
Lee JW; Chung HY; Ehrlich LA; Jelinek DF; Callander NS; Roodman GD; Choi SJ
Blood; 2004 Mar; 103(6):2308-15. PubMed ID: 14615378
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in multiple myeloma.
Moscinski LC; Ballester OF
Hematol Oncol; 1994; 12(3):111-23. PubMed ID: 7525447
[TBL] [Abstract][Full Text] [Related]
16. New insights into role of microenvironment in multiple myeloma.
Tricot GJ
Int J Hematol; 2002 Aug; 76 Suppl 1():334-6. PubMed ID: 12430876
[TBL] [Abstract][Full Text] [Related]
17. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.
Klein B; Zhang XG; Jourdan M; Content J; Houssiau F; Aarden L; Piechaczyk M; Bataille R
Blood; 1989 Feb; 73(2):517-26. PubMed ID: 2783861
[TBL] [Abstract][Full Text] [Related]
18. In vitro growth of human multiple myeloma: implications for biology and therapy.
Caligaris-Cappio F; Gregoretti MG; Ghia P; Bergui L
Hematol Oncol Clin North Am; 1992 Apr; 6(2):257-71. PubMed ID: 1582973
[TBL] [Abstract][Full Text] [Related]
19. C-kit ligand (SCF) in human multiple myeloma cells.
Lemoli RM; Fortuna A
Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
[TBL] [Abstract][Full Text] [Related]
20. Production of interleukin-1 by bone marrow myeloma cells.
Cozzolino F; Torcia M; Aldinucci D; Rubartelli A; Miliani A; Shaw AR; Lansdorp PM; Di Guglielmo R
Blood; 1989 Jul; 74(1):380-7. PubMed ID: 2665838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]